Vitasora Health (ASX:VHL) Valuation Rank


What is Vitasora Health Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Vitasora Health Valuation Rank Related Terms

Vitasora Health Business Description

Other Exchanges VHLUF:USA
Address 432 Street Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.